Clinical Trials Sponsored by Edwards Foundation, Inc.
Total 1044 results
-
Marshall UniversityEdwards Foundation, Inc.TerminatedChronic Lymphocytic Leukemia | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple MyelomaUnited States
-
Edwards LifesciencesDexCom, Inc.; Medical Device Consultants, Inc.Completed
-
Edward R. Teitel, M.D.Completed
-
EDUARDO ALBENIZFundacion Miguel ServetRecruiting
-
Royal Brompton & Harefield NHS Foundation TrustImperial College London; Edwards LifesciencesNot yet recruitingValve Heart Disease | CFD
-
University Hospital Southampton NHS Foundation...University of Southampton; Edwards LifesciencesNot yet recruiting
-
Washington University School of MedicineEdward P. Evans FoundationRecruitingCardiovascular Diseases | Aged | Geriatrics | Geriatric SyndromesUnited States
-
Jean EdwardRobert Wood Johnson FoundationCompletedPediatric Cancer | Financial StressUnited States
-
Hospital Universitário Professor Edgard SantosOswaldo Cruz FoundationCompleted
-
NSABP Foundation IncCompletedRectal CancerUnited States
-
NSABP Foundation IncWithdrawnColorectal CancerUnited States
-
NSABP Foundation IncCompletedBreast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIB Breast Cancer | Locally AdvancedUnited States
-
NSABP Foundation IncCompleted
-
CHDI Foundation, Inc.RecruitingHuntington's DiseaseUnited States, Canada, Belgium, Spain, Australia, Germany, France, Netherlands, United Kingdom, New Zealand, Argentina, Austria, Chile, Colombia, Denmark, Ireland, Italy, Poland, Portugal, Switzerland
-
NSABP Foundation IncCompletedColorectal Cancer MetastaticUnited States
-
CHDI Foundation, Inc.UnknownHuntington DiseaseUnited States, United Kingdom
-
CHDI Foundation, Inc.CompletedHuntington's DiseaseSweden, Denmark, Netherlands, Norway
-
CHDI Foundation, Inc.CompletedHuntington's DiseaseSweden, Denmark, Netherlands, Norway
-
CHDI Foundation, Inc.Medpace, Inc.Active, not recruitingNatural History Study in Huntington Disease Gene Expansion Carriers (HDGECs) - SHIELD HD (SHIELD HD)Huntington DiseaseUnited States, Canada, France, Germany, United Kingdom
-
NSABP Foundation IncEisai Inc.CompletedBreast Cancer | HER2-negative Breast CancerUnited States, Canada
-
Robert EdwardsMerck Sharp & Dohme LLC; AIM ImmunoTech Inc.RecruitingOvarian Cancer RecurrentUnited States
-
Edward Maytin, MD, PhDDUSA Pharmaceuticals, Inc.CompletedBasal Cell Nevus SyndromeUnited States
-
Thomas Edward PidgeonUniversity of BirminghamUnknownCarpal Tunnel SyndromeUnited Kingdom
-
Life Extension Foundation Inc.CompletedSleep Disorder | Insomnia | DyssomniaUnited States
-
GlaxoSmithKlineNSABP Foundation IncCompleted
-
Kessler FoundationSaebo, Inc.Completed
-
NSABP Foundation IncPuma Biotechnology, Inc.Completed
-
NSABP Foundation IncPuma Biotechnology, Inc.Active, not recruitingMetastatic Colorectal CancerUnited States
-
NSABP Foundation IncPuma Biotechnology, Inc.CompletedBreast CancerUnited States, Canada, Puerto Rico, Italy, Spain
-
COPD FoundationViatris Inc.Recruiting
-
Agenus Inc.GOG FoundationActive, not recruitingCervical CancerUnited States, Korea, Republic of, Taiwan, Brazil, Mexico, Peru, Thailand
-
NSABP Foundation IncBayerTerminatedStage III (IIIB or IIIC) Colon CancerUnited States
-
Stern Cardiovascular Foundation, Inc.Terminated
-
Foundation MedicineQuintiles, Inc.CompletedCancer | Neoplasm Metastasis | TumorUnited States
-
Life Extension Foundation Inc.CompletedAlzheimer's DiseaseUnited States
-
Neurologique Foundation, Inc.MallinckrodtTerminated
-
NSABP Foundation IncSanofiWithdrawnMetastatic Colorectal Cancer | Colorectal Cancer
-
NSABP Foundation IncAmgenWithdrawn
-
NSABP Foundation IncAstraZenecaCompletedBreast NeoplasmsUnited States
-
ETOP IBCSG Partners FoundationNSABP Foundation IncCompletedBreast CancerSpain, United States, Australia, Belgium, Switzerland, Canada, Peru, Netherlands, Hungary, South Africa
-
ImmunoGen, Inc.GOG FoundationRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Korea, Republic of, Spain, Australia, Canada, United Kingdom, Italy, Czechia, Philippines, Israel, Belgium
-
Target ALS Foundation, Inc.RecruitingTarget ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures (TALSLB)Movement Disorders | Motor Neuron Disease | Amyotrophic Lateral Sclerosis | Degenerative DisorderUnited States
-
NSABP Foundation IncGlaxoSmithKlineUnknownInvasive Breast CancerUnited States, Canada, Puerto Rico
-
NSABP Foundation IncPfizerCompleted
-
Kessler FoundationSaebo, Inc.CompletedStroke | HemiplegiaUnited States
-
Genentech, Inc.Flatiron Health, Inc.; Foundation Medicine, Inc.CompletedNon-Small Cell Lung Cancer (NSCLC) | Small-Cell Lung Cancer (SCLC)United States
-
RTOG Foundation, Inc.Pfizer; Astellas Pharma IncActive, not recruitingProstate CancerUnited States, Canada
-
NSABP Foundation IncNovartis Pharmaceuticals; Natera, Inc.Withdrawn
-
Mylan Inc.Cystic Fibrosis FoundationCompletedPseudomonas Aeruginosa in Cystic FibrosisUnited States
-
Savara Inc.Cystic Fibrosis Foundation; Synteract, Inc.CompletedCystic FibrosisUnited States